SUPERNUS PHARMACEUTICALS, INC. Depreciation
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Depreciation of $160.00 thousand for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2015-08-07
- SUPERNUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2015-06-30 was $160.00K, a 9.09% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2015-03-31 was $156.00K, a 7.69% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2014-12-31 was $170.00K, a 8.28% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2014-09-30 was $184.00K, a 28.67% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for fiscal 2014 was $699.00K, a 36.52% increase from fiscal 2013.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for fiscal 2013 was $512.00K, a 20.25% decline from fiscal 2012.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for fiscal 2012 was $642.00K, a 1.23% decline from fiscal 2011.
- SUPERNUS PHARMACEUTICALS, INC. depreciation for fiscal 2011 was $650.00K, a 32.22% decline from fiscal 2010.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2015-06-30 | $160.00K 10-Q · filed 2015-08-07 | $317.00K 10-Q · filed 2015-08-07 | $486.00K derived: sum of 3 quarters · filed 2015-08-07 | $670.00K derived: sum of 4 quarters · filed 2015-08-07 | ||
| 2015-03-31 | $156.00K 10-Q · filed 2015-05-06 | $326.00K derived: sum of 2 quarters · filed 2015-05-06 | $510.00K derived: sum of 3 quarters · filed 2015-05-06 | $686.00K derived: sum of 4 quarters · filed 2015-08-07 | ||
| 2014-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $354.00K derived: sum of 2 quarters · filed 2015-03-12 | $530.00K derived: sum of 3 quarters · filed 2015-08-07 | $699.00K 10-K · filed 2015-03-12 | ||
| 2014-09-30 | $184.00K 10-Q · filed 2014-11-12 | $360.00K derived: sum of 2 quarters · filed 2015-08-07 | $529.00K 10-Q · filed 2014-11-12 | $686.00K derived: sum of 4 quarters · filed 2015-08-07 | ||
| 2014-06-30 | $176.00K 10-Q · filed 2015-08-07 | $345.00K 10-Q · filed 2015-08-07 | $502.00K derived: sum of 3 quarters · filed 2015-08-07 | $645.00K derived: sum of 4 quarters · filed 2015-08-07 | ||
| 2014-03-31 | $169.00K 10-Q · filed 2015-05-06 | $326.00K derived: sum of 2 quarters · filed 2015-05-06 | $469.00K derived: sum of 3 quarters · filed 2015-05-06 | $574.00K derived: sum of 4 quarters · filed 2015-05-06 | ||
| 2013-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $300.00K derived: sum of 2 quarters · filed 2015-03-12 | $405.00K derived: sum of 3 quarters · filed 2015-03-12 | $512.00K 10-K · filed 2015-03-12 | ||
| 2013-09-30 | $143.00K 10-Q · filed 2014-11-12 | $248.00K derived: sum of 2 quarters · filed 2014-11-12 | $355.00K 10-Q · filed 2014-11-12 | $518.00K derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | $105.00K 10-Q · filed 2014-08-12 | $105.00M 10-Q · filed 2013-08-14 | $211.00K 10-Q · filed 2014-08-12 | $211.00M 10-Q · filed 2013-08-14 | $375.00K derived: sum of 3 quarters · filed 2015-03-12 | $529.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $106.00K 10-Q · filed 2014-05-13 | $270.00K derived: sum of 2 quarters · filed 2015-03-12 | $424.00K derived: sum of 3 quarters · filed 2015-03-12 | $156.42M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2012-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $318.00K derived: sum of 2 quarters · filed 2015-03-12 | $156.32M derived: sum of 3 quarters · filed 2015-03-12 | $642.00K 10-K · filed 2015-03-12 | ||
| 2012-09-30 | $154.00K 10-Q · filed 2013-11-13 | $156.15M derived: sum of 2 quarters · filed 2013-11-13 | $478.00K 10-Q · filed 2013-11-13 | $156.49M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2012-06-30 | $156.00M 10-Q · filed 2013-08-14 | $156.00K 10-Q · filed 2012-08-13 | $323.00M 10-Q · filed 2013-08-14 | $323.00K 10-Q · filed 2012-08-13 | $156.34M derived: sum of 3 quarters · filed 2014-03-21 | $156.50M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $167.00K 10-Q · filed 2013-05-15 | $338.00K derived: sum of 2 quarters · filed 2014-03-21 | $505.00K derived: sum of 3 quarters · filed 2014-03-21 | $666.00K derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2011-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $338.00K derived: sum of 2 quarters · filed 2014-03-21 | $499.00K derived: sum of 3 quarters · filed 2014-03-21 | $650.00K 10-K · filed 2014-03-21 | ||
| 2011-09-30 | $167.00K 10-Q · filed 2012-11-02 | $328.00K derived: sum of 2 quarters · filed 2012-11-02 | $479.00K 10-Q · filed 2012-11-02 | |||
| 2011-06-30 | $161.00K 10-Q · filed 2012-08-13 | $312.00K 10-Q · filed 2012-08-13 | ||||
| 2010-12-31 | $959.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |